An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients

Thromb Haemost. 2011 May;105(5):931-2. doi: 10.1160/TH10-11-0757. Epub 2011 Feb 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Blood Coagulation Tests*
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / complications
  • Neoplasms / diagnosis*
  • Neoplasms / drug therapy
  • Neoplasms / mortality
  • Neoplasms / physiopathology
  • Predictive Value of Tests
  • Protein C / metabolism
  • Sensitivity and Specificity
  • Thrombin / metabolism*
  • Venous Thromboembolism / diagnosis*
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / mortality
  • Venous Thromboembolism / physiopathology
  • Venous Thromboembolism / prevention & control

Substances

  • Protein C
  • Thrombin